Metraipolis › archive › dc_7473ee96119e
Hypersensitivity reactions to dengue vaccine TAK-003 (Qdenga®) following an immunization campaign targeting children and adolescents — Europe PMC PMID:42384997
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42384997
- DOI
- 10.1590/0037-8682-0198-2026
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-18T16:17:07.564Z
- SHA-256 of the archived text
e27d506f1c0a2b0c57af83fefa87eafd37e6ac4dab48af37fe25ee6070680343- Stable URL of this page
https://metraipolis.com/documento/dc_7473ee96119e
How to cite
Hypersensitivity reactions to dengue vaccine TAK-003 (Qdenga®) following an immunization campaign targeting children and adolescents — Europe PMC PMID:42384997 — Europe PMC (en), https://europepmc.org/article/MED/42384997 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7473ee96119e (Metraipolis archive dc_7473ee96119e, sha256 e27d506f1c0a2b0c57af83fefa87eafd37e6ac4dab48af37fe25ee6070680343)
BibTeX
@misc{dc7473ee96119e,
title = {Hypersensitivity reactions to dengue vaccine TAK-003 (Qdenga®) following an immunization campaign targeting children and adolescents — Europe PMC PMID:42384997},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42384997},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7473ee96119e; sha256 e27d506f1c0a2b0c57af83fefa87eafd37e6ac4dab48af37fe25ee6070680343},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42384997. Agents can read the archived copy with the MCP tool read_document.